Archives for January 27, 2005

← 2005

Inamed botulinum toxin to hit Europe

Inamed a global health care company, and its partner Ipsen, a European pharmaceutical group, are to distribute rights of Ipsen's botulinum toxin Type A product in selected international markets, including Europe.

Synthetic musk could pose toxicity risk

A scientific study has shown that artificial musk fragrance can increase sensitivity to toxins in mussels, indicating possible implications for human health. Simon Pitman reports on the findings and industry's reaction.